Intense research in the field of cancer, autoimmune diseases and various infection has revealed the interaction of BTLA with its ligand HVEM has a potent inhibitory effect on adaptive, majorly T-cell mediated, immune response [26]. The gene discussed is TNFRSF14; the disease is autoimmune disease.